Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children

Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children

Oncolytic engineered herpes simplex viruses (HSVs) possess many biologic and functional attributes that support their use in clinical trials in children with solid tumors. Tumor cells, in an effort to escape regulatory mechanisms that would impair their growth and progression, have removed many mech...

Full description

Bibliographic Details
Main Authors:	Gregory K Friedman, Elizabeth A Beierle, George Yancey Gillespie, James M Markert, Alicia M Waters, Chun-Yu Chen, Nicholas L Denton, Kellie B Haworth, Brian Hutzen, Jennifer L Leddon, Keri A Streby, Pin-Yi Wang, Timothy P Cripe
Format:	Article
Language:	English
Published:	Elsevier 2015-01-01
Series:	Molecular Therapy: Oncolytics
Online Access:	http://www.sciencedirect.com/science/article/pii/S2372770516300183

Similar Items

Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children
by: Timothy P Cripe, et al.
Published: (2015-01-01)

Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma
by: Alicia M. Waters, et al.
Published: (2016-10-01)

Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma.
by: Lauren A Gillory, et al.
Published: (2013-01-01)

Oncolytic Herpes Simplex Virus Therapy for the Treatment of Pediatric Rhabdomyosarcoma
by: Leddon, Jennifer
Published: (2015)

Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumors.
by: Michael L Megison, et al.
Published: (2014-01-01)

Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
by: Jie Yin, et al.
Published: (2017-06-01)

Oncolytic herpes simplex virus and immunotherapy
by: Wenqing Ma, et al.
Published: (2018-12-01)

Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment
by: Nicholas L. Denton, et al.
Published: (2018-12-01)

Preclinical Evaluation of Oncolytic Δγ134.5 Herpes Simplex Virus Expressing Interleukin-12 for Therapy of Breast Cancer Brain Metastases
by: James J. Cody, et al.
Published: (2012-01-01)

Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates
by: Kevin A. Cassady, et al.
Published: (2017-06-01)

Enhancement of oncolytic herpes simplex type 1 virotherapy
by: Delwar, Zahid M.
Published: (2017)

Oncolytic Herpes Simplex Virus-Based Therapies for Cancer
by: Norah Aldrak, et al.
Published: (2021-06-01)

Histone deacetylase inhibitors improve the replication of oncolytic herpes simplex virus in breast cancer cells.
by: James J Cody, et al.
Published: (2014-01-01)

Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors
by: Adam W. Studebaker, et al.
Published: (2017-09-01)

Chimeric HCMV/HSV-1 and Δγ134.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memory
by: Mohammed G. Ghonime, et al.
Published: (2018-02-01)

The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
by: Nguyen HM, et al.
Published: (2021-02-01)

Presage of oncolytic virotherapy for oral cancer with herpes simplex virus
by: Yoshiaki Yura
Published: (2017-05-01)

TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma
by: Brian Hutzen, et al.
Published: (2017-12-01)

Herpes Simplex Virus Oncolytic Immunovirotherapy: The Blossoming Branch of Multimodal Therapy
by: Laura Menotti, et al.
Published: (2020-11-01)

Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
by: Jayeeta Ghose, et al.
Published: (2021-03-01)

To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses
by: Kevin A. Cassady, et al.
Published: (2016-02-01)

Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models
by: Chun-Yu Chen, et al.
Published: (2017-05-01)

Oncolytic virotherapy for pediatric malignancies: future prospects
by: Waters AM, et al.
Published: (2016-08-01)

Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer
by: Yanghee Woo, et al.
Published: (2020-03-01)

Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
by: Jan B. Boscheinen, et al.
Published: (2019-01-01)

Construction and characterisation of second generation oncolytic herpes simplex viruses for cancer therapy
by: Dunn, Paul Damien
Published: (2003)

Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion
by: Julia V. Cockle, et al.
Published: (2017-06-01)

The Role of Natural Killer Cells in the Context of Oncolytic Herpes Simplex Virotherapy for Glioblastoma
by: Alvarez-Breckenridge, Christopher
Published: (2011)

The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies
by: Joshua D. Bernstock, et al.
Published: (2021-06-01)

A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma
by: Iwai Soichi, et al.
Published: (2011-06-01)

Oncolytic virotherapy using herpes simplex virus: how far have we come?
by: Sokolowski NAS, et al.
Published: (2015-11-01)

Entry of Oncolytic Herpes Simplex Virus into Human Squamous Cell Carcinoma Cells by Ultrasound
by: Shusuke Okunaga, et al.
Published: (2015-10-01)

Oncolytic Herpes Simplex Virus-based Strategies: Toward a Breakthrough in Glioblastoma Therapy
by: Jianfang eNing, et al.
Published: (2014-06-01)

Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus
by: Takuma Suzuki, et al.
Published: (2021-09-01)

Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo
by: Yin L, et al.
Published: (2017-02-01)

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment
by: Ifeanyi Kingsley Uche, et al.
Published: (2021-06-01)

Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins
by: Xiao-Qin Liu, et al.
Published: (2018-01-01)

Engineering and Characterization of Oncolytic Vaccinia Virus Expressing Truncated Herpes Simplex Virus Thymidine Kinase
by: S. M. Bakhtiar Ul Islam, et al.
Published: (2020-01-01)

Oncolytic herpes simplex virus kills stem-like tumor-initiating colon cancer cells
by: Susanne G Warner, et al.
Published: (2016-01-01)

Proteomic Analysis of Secretomes of Oncolytic Herpes Simplex Virus-Infected Squamous Cell Carcinoma Cells
by: Shinya Tada, et al.
Published: (2018-01-01)

Cannot write session to /tmp/vufind_sessions/sess_c5oqbaj6tba6ik28lcg2tqp87h